These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21884469)

  • 21. Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis.
    Hidaka T; Suzuki K
    Ther Apher; 1997 Aug; 1(3):212-4. PubMed ID: 10225740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs.
    Minamiguchi K; Kitazato KT; Sasaki E; Nagase H; Kitazato K
    Thromb Haemost; 1997 Jun; 77(6):1148-53. PubMed ID: 9241748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in the apheresis procedure for the treatment of inflammatory bowel disease.
    Pineda AA
    Inflamm Bowel Dis; 2006 Jan; 12 Suppl 1():S10-4. PubMed ID: 16378005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.
    Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
    Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of leukocytapheresis.
    Nagase K; Sawada K; Ohnishi K; Egashira A; Ohkusu K; Shimoyama T
    Ther Apher; 1998 May; 2(2):120-4. PubMed ID: 10225712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
    Fujita H; Sakuma R; Fujimoto S; Hazama Y; Ohtake C; Moriyama A; Kuhara K; Nishimura S
    Transfus Med; 2012 Jun; 22(3):186-91. PubMed ID: 22519457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
    Pierce DA; Rocco MV
    Pharmacotherapy; 2010 Nov; 30(11):1150-8. PubMed ID: 20973688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.
    Morgera S; Scholle C; Melzer C; Slowinski T; Liefeld L; Baumann G; Peters H; Neumayer HH
    Nephron Clin Pract; 2004; 98(1):c35-40. PubMed ID: 15361702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of filtration leukocytapheresis(LCAP) in rheumatoid arthritis(RA)].
    Ueki Y; Takashima H; Matsumoto K; Miyake S; Hidaka T; Suzuki K; Eguchi K
    Nihon Rinsho; 2002 Dec; 60(12):2296-303. PubMed ID: 12510353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leukocytapheresis for therapy of rheumatoid arthritis].
    Ueki Y; Eguchi K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():649-52. PubMed ID: 15799436
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphocytapheresis.
    Takenaka Y
    Artif Organs; 1996 Aug; 20(8):914-6. PubMed ID: 8853806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration of citrate anticoagulant in peripheral blood progenitor cell collections.
    Burger SR; Fautsch SK; Stroncek DF; McCullough J
    Transfusion; 1996 Sep; 36(9):798-801. PubMed ID: 8823453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of uremic patients with high bleeding risk].
    Ogata H; Kinugasa E
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():70-4. PubMed ID: 15250271
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.
    Morimoto N; Henmi S; Yoshida M; Mukohara N
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):726-8. PubMed ID: 22541513
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of anticoagulation for hemodialysis patients: survey of 842 cases in seven hemodialysis centers].
    Sun XF; Xiao Q; Wang Y; Hao LR; Lin HL; Zhang ZM; Li JJ; Chen XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):577-81. PubMed ID: 19595154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action.
    Mitsuyama K; Sata M
    Cytotherapy; 2009; 11(2):229-37. PubMed ID: 19241197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AANA Journal course: update for nurse anesthetists--low molecular weight heparin: pharmacology and regional anesthetic implications.
    Thames BC; Allen DO
    AANA J; 2000 Aug; 68(4):357-64. PubMed ID: 11125607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis.
    Yamasaki K; Nishi K; Tsukigawa K; Taguchi K; Otagiri M; Seo H
    Biol Pharm Bull; 2021; 44(2):259-265. PubMed ID: 33518678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.